Abstract

In the context of a hunt for a postulated hormone that is tissue-mass inhibiting and reproductively associated, there is described probable relatedness to a granin protein. A 7–8 kDa polypeptide candidate (gels/MS) appeared in a bioassay-guided fractionation campaign involving sheep plasma. An N-terminal sequence of 14 amino acids was obtained for the polypeptide by Edman degradation. Bioinformatics and molecular biology failed to illuminate any ovine or non-ovine protein which might relate to this sequence. The N-terminal sequence was synthesized as the 14mer EPL001 peptide and surprisingly found to be inhibitory in an assay in vivo of compensatory renal growth in the rat and modulatory of nematode fecundity, in line with the inhibitory hormone hypothesis. Antibodies were raised to EPL001 and their deployment upheld the hypothesis that the EPL001 amino acid sequence is meaningful and relevant, notwithstanding bioinformatic obscurity. Immunohistochemistry (IHC) in sheep, rodents and humans yielded staining of seeming endocrine relevance (e.g. hypothalamus, gonads and neuroendocrine cells in diverse tissues), with apparent upregulation in certain human tumours (e.g. pheochromocytoma). Discrete IHC staining in Drosophila melanogaster embryo brain was seen in glia and in neuroendocrine cells, with staining likely in the corpus cardiacum. The search for the endogenous antigen involved immunoprecipitation (IP) followed by liquid chromatography and mass spectrometry (LC–MS). Feedstocks were PC12 conditioned medium and aqueous extract of rat hypothalamus—both of which had anti-proliferative and pro-apoptotic effects in an assay in vitro involving rat bone marrow cells, which inhibition was subject to prior immunodepletion with an anti-EPL001 antibody—together with fruit fly embryo material. It is concluded that the mammalian antigen is likely secretogranin II (SgII) related. The originally seen 7–8 kDa polypeptide is suggested to be a new proteoform of secretogranin II of ∼70 residues, SgII-70, with the anti-EPL001 antibody seeing a discontinuous epitope. The fly antigen is probably Q9W2X8 (UniProt), an uncharacterised protein newly disclosed as a granin and provisionally dubbed macrogranin I (MgI). SgII and Q9W2X8 merit further investigation in the context of tissue-mass inhibition.

Highlights

  • A tissue-mass inhibitory hormone has been postulated, having gonadal and hypothalamic aspects (Hart, 2014), potentially filling a gap in scientific knowledge as to how the size of internal organs is constrained

  • An excursion into the fruit fly proved instructive, to gain insight into a simpler system, producing further images of seeming neuroendocrine relevance while indicating that the use of frozen unfixed tissue as starting material was to be eschewed in favour of formalin-fixed tissue, with antigen retrieval

  • There was no commonality between the rat ‘unfixed test overlappers’ and the rat ‘fixed test overlappers’

Read more

Summary

Introduction

A tissue-mass inhibitory hormone has been postulated, having gonadal and hypothalamic aspects (Hart, 2014), potentially filling a gap in scientific knowledge as to how the size of internal organs is constrained. This plasma fraction yielded a polypeptide candidate with a molecular weight of ∼7.5 kDa in MALDI-TOF mass spectrometry (Hart, 2013), representing ∼70 amino acids (aa). The sequence was synthesized to provide a 14mer peptide, which was given the proprietary designation EPL001 This proved to have dose-dependent tissue-reducing properties in an in vivo model system involving compensatory renal growth in the unilaterally nephrectomised rat (Haylor et al, 2009). An anti-EPL001 antibody targeted at the C-terminal end of the peptide has been deployed here in an attempt to purify

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.